These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31665857)

  • 21. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.
    Clay J; Kulasekararaj AG; Potter V; Grimaldi F; McLornan D; Raj K; de Lavallade H; Kenyon M; Pagliuca A; Mufti GJ; Marsh JC
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1711-6. PubMed ID: 25016195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
    Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
    Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical observation of haploidentical-hematopoietic stem cell transplantation combined with human umbilical cord-derived mesenchymal stem cells for severe aplastic anemia-II].
    Xu LX; Liu ZY; Wu YM; Cao YB; Li XH; Yan B; Yang XL; DA WM; Wu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):774-8. PubMed ID: 24989293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia.
    Lee JW; Cho BS; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Min WS; Park CW
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):101-8. PubMed ID: 20601037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
    Scheinberg P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic transplantation for aplastic anemia.
    Eapen M
    Hematology; 2012 Apr; 17 Suppl 1():S15-7. PubMed ID: 22507769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.
    Onishi Y; Mori T; Kako S; Koh H; Uchida N; Kondo T; Kobayashi T; Yabe H; Miyamoto T; Kato K; Suzuki R; Nakao S; Yamazaki H;
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2137-2142. PubMed ID: 28844947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.
    Bacigalupo A; Socié G; Hamladji RM; Aljurf M; Maschan A; Kyrcz-Krzemien S; Cybicka A; Sengelov H; Unal A; Beelen D; Locasciulli A; Dufour C; Passweg JR; Oneto R; Signori A; Marsh JC;
    Haematologica; 2015 May; 100(5):696-702. PubMed ID: 25616576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upfront Matched Unrelated Donor Transplantation in Aplastic Anemia.
    Clesham K; Dowse R; Samarasinghe S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):619-628. PubMed ID: 30047415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
    Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Unrelated Donor Peripheral Blood Stem Cell Transplantation Combined with Umbilical Cord Mesenchymal Stem Cells in Patients with Hematologic Malignancies].
    Zhang XT; Duan LN; Ding L; Zhu L; Yan HM; Wang ZD; Wang S; Zheng XL; Dong L; Xue M; Liu J; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1445-50. PubMed ID: 26524054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia.
    Benesch M; Urban C; Sykora KW; Schwinger W; Zintl F; Lackner H; Lang P; Handgretinger R
    Br J Haematol; 2004 Apr; 125(1):58-63. PubMed ID: 15015969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China.
    Zeng Y; Wang S; Wang J; Liu L; Su Y; Lu Z; Zhang X; Zhang Y; Zhong JF; Peng L; Liu Q; Lu Y; Gao L; Zhang X
    Sci Rep; 2018 Feb; 8(1):2479. PubMed ID: 29410500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
    Xu LP; Jin S; Wang SQ; Xia LH; Bai H; Gao SJ; Liu QF; Wang JM; Wang X; Jiang M; Zhang X; Wu DP; Huang XJ
    J Hematol Oncol; 2017 Jan; 10(1):25. PubMed ID: 28107815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
    Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
    Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.